hydromorphone has been researched along with sufentanil in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brockmöller, J; Friesacher, HR; Meyer, MJ; Neumann, VE; Tzvetkov, MV; Zdrazil, B | 1 |
| Bohl, S; Chapman, CR; Coda, BA; Donaldson, G; O'Sullivan, B; Shen, DD | 1 |
| Fechner, J; Fröhlich, K; Ihmsen, H; Jeleazcov, C; Krajinovic, L; Mell, J; Saari, TI; Schüttler, J | 1 |
| Fechner, J; Fröhlich, K; Ihmsen, H; Jeleazcov, C; Mell, J; Saari, TI; Schüttler, J | 1 |
| Cheng, L; Feng, Z; Li, H; Peng, Z; Wu, J; Xu, X; Yang, Y; Ye, S; Zhu, L | 1 |
| Feng, Z; Guo, J; Guo, X; Peng, Z; Zhang, Y | 1 |
| Chen, J; Du, Z; Duan, G; Li, H; Liao, W; Peng, J; Yan, G; Yang, G; Yu, Z | 1 |
| Chen, L; Chen, X; Liang, H; Lie, D; Liu, D; Pan, Y; Peng, L; Song, X; Wang, H; Wang, Y; Wu, Z; Zhao, B | 1 |
| Guo, YY; Li, ZH; Lu, B; Nie, ZB; Zhang, R | 1 |
| Chen, Y; Jiang, R; Jin, L; Mao, W; Tian, W; Xu, Z; Yu, H | 1 |
2 review(s) available for hydromorphone and sufentanil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hydromorphone vs sufentanil in patient-controlled analgesia for postoperative pain management: A meta-analysis.
Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthetics, Intravenous; Humans; Hydromorphone; Narcotics; Pain, Postoperative; Sufentanil | 2022 |
7 trial(s) available for hydromorphone and sufentanil
| Article | Year |
|---|---|
Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation.
Topics: Adolescent; Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Bone Marrow Transplantation; Double-Blind Method; Female; Humans; Hydromorphone; Male; Middle Aged; Morphine; Mouth Mucosa; Palliative Care; Postoperative Complications; Stomatitis; Sufentanil | 1997 |
Population pharmacokinetic modeling of hydromorphone in cardiac surgery patients during postoperative pain therapy.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Analgesia, Patient-Controlled; Analgesics, Opioid; Cardiac Surgical Procedures; Computer Simulation; Data Interpretation, Statistical; Drug Interactions; Female; Hemodynamics; Humans; Hydromorphone; Infusions, Intralesional; Male; Middle Aged; Pain, Postoperative; Prospective Studies; Reproducibility of Results; Single-Blind Method; Sufentanil; Thoracotomy | 2014 |
Influence of intensive care treatment on the protein binding of sufentanil and hydromorphone during pain therapy in postoperative cardiac surgery patients.
Topics: Adult; Aged; Algorithms; Analgesia, Patient-Controlled; Analgesics, Opioid; Cardiac Surgical Procedures; Critical Care; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Male; Middle Aged; Nonlinear Dynamics; Pain, Postoperative; Prospective Studies; Protein Binding; Regression Analysis; Sufentanil; Thoracotomy | 2014 |
Prospective investigation of intravenous patient-controlled analgesia with hydromorphone or sufentanil: impact on mood, opioid adverse effects, and recovery.
Topics: Administration, Intravenous; Affect; Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthesia Recovery Period; China; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydromorphone; Length of Stay; Male; Middle Aged; Pain, Postoperative; Patient Satisfaction; Postoperative Complications; Prospective Studies; Sufentanil; Treatment Outcome | 2018 |
Effects of patient-controlled analgesia with hydromorphone or sufentanil on postoperative pulmonary complications in patients undergoing thoracic surgery: a quasi-experimental study.
Topics: Adult; Analgesia, Patient-Controlled; Benzimidazoles; Blood Gas Analysis; Bridged Bicyclo Compounds, Heterocyclic; Double-Blind Method; Female; Humans; Hydromorphone; Intensive Care Units; Length of Stay; Lung Diseases; Male; Middle Aged; Pain, Postoperative; Postoperative Complications; Sufentanil; Tetrahydronaphthalenes; Thoracic Surgical Procedures | 2018 |
Effectiveness of analgesia with hydromorphone hydrochloride for postoperative pain following surgical repair of structural congenital malformations in children: a randomized controlled trial.
Topics: Analgesics, Opioid; Anesthesia, General; Child, Preschool; Congenital Abnormalities; Dose-Response Relationship, Drug; Emergence Delirium; Female; Flurbiprofen; Humans; Hydromorphone; Infant; Male; Pain, Postoperative; Prospective Studies; Single-Blind Method; Sufentanil | 2021 |
Patient-controlled intravenous analgesia with opioids after thoracoscopic lung surgery: a randomized clinical trial.
Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Humans; Hydromorphone; Lung; Oxycodone; Pain, Postoperative; Postoperative Nausea and Vomiting; Sufentanil | 2022 |
5 other study(ies) available for hydromorphone and sufentanil
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1.
Topics: Analgesics, Opioid; HEK293 Cells; Humans; Inhibitory Concentration 50; Models, Molecular; Organic Cation Transporter 1; Permeability; Protein Conformation | 2019 |
Patient-Controlled Intravenous Analgesia for Advanced Cancer Patients with Pain: A Retrospective Series Study.
Topics: Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Cancer Pain; Female; Humans; Hydromorphone; Male; Middle Aged; Oxycodone; Pain Management; Patient Satisfaction; Retrospective Studies; Sufentanil | 2018 |